<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Tue, 27 Oct 2026 06:18:54 -0400--><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/">
    <channel>
        <title>Rezolute, Inc. (RZLT) SEC Filings</title>
        <link>https://ir.rezolutebio.com/sec-filings/rss</link>
        <description>Rezolute, Inc. (RZLT) - SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_ccfa9d9a38d9c21c9cf5ba58fc58a234/rezolutebio/files/theme/images/logo-sm.png</url>
                <title>Rezolute, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.rezolutebio.com/sec-filings/content/0000912282-26-001376/0000912282-26-001376.pdf</link>
                <pubDate>Fri, 23 Oct 26 00:00:00 -0400</pubDate>
                <guid>https://ir.rezolutebio.com/sec-filings/content/0000912282-26-001376/0000912282-26-001376.pdf</guid>
                                                                
            </item>
                    <item>
                <title><![CDATA[DEF 14A - Definitive proxy statements]]></title>
                <description><![CDATA[DEF 14A]]></description>
                <link>https://ir.rezolutebio.com/sec-filings/content/0001104659-26-117868/0001104659-26-117868.pdf</link>
                <pubDate>Wed, 21 Oct 26 00:00:00 -0400</pubDate>
                <guid>https://ir.rezolutebio.com/sec-filings/content/0001104659-26-117868/0001104659-26-117868.pdf</guid>
                                                                
            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-99.1]]></description>
                <link>https://ir.rezolutebio.com/sec-filings/content/0001104659-26-115874/0001104659-26-115874.pdf</link>
                <pubDate>Wed, 14 Oct 26 00:00:00 -0400</pubDate>
                <guid>https://ir.rezolutebio.com/sec-filings/content/0001104659-26-115874/0001104659-26-115874.pdf</guid>
                                                                
            </item>
                    <item>
                <title><![CDATA[PRE 14A - Preliminary proxy statement not related to a contested matter or merger/acquisition]]></title>
                <description><![CDATA[PRE 14A]]></description>
                <link>https://ir.rezolutebio.com/sec-filings/content/0001104659-26-114396/0001104659-26-114396.pdf</link>
                <pubDate>Wed, 07 Oct 26 00:00:00 -0400</pubDate>
                <guid>https://ir.rezolutebio.com/sec-filings/content/0001104659-26-114396/0001104659-26-114396.pdf</guid>
                                                                
            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-99.1]]></description>
                <link>https://ir.rezolutebio.com/sec-filings/content/0001104659-26-113503/0001104659-26-113503.pdf</link>
                <pubDate>Mon, 05 Oct 26 00:00:00 -0400</pubDate>
                <guid>https://ir.rezolutebio.com/sec-filings/content/0001104659-26-113503/0001104659-26-113503.pdf</guid>
                                                                
            </item>
                    <item>
                <title><![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]></title>
                <description><![CDATA[8 Related Documents: 10-K, EX-4.1, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.rezolutebio.com/sec-filings/content/0001104659-26-110420/0001104659-26-110420.pdf</link>
                <pubDate>Thu, 24 Sep 26 00:00:00 -0400</pubDate>
                <guid>https://ir.rezolutebio.com/sec-filings/content/0001104659-26-110420/0001104659-26-110420.pdf</guid>
                                                                
            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-99.1]]></description>
                <link>https://ir.rezolutebio.com/sec-filings/content/0001104659-26-110412/0001104659-26-110412.pdf</link>
                <pubDate>Thu, 24 Sep 26 00:00:00 -0400</pubDate>
                <guid>https://ir.rezolutebio.com/sec-filings/content/0001104659-26-110412/0001104659-26-110412.pdf</guid>
                                                                
            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.rezolutebio.com/sec-filings/content/0000912282-26-001216/0000912282-26-001216.pdf</link>
                <pubDate>Thu, 03 Sep 26 00:00:00 -0400</pubDate>
                <guid>https://ir.rezolutebio.com/sec-filings/content/0000912282-26-001216/0000912282-26-001216.pdf</guid>
                                                                
            </item>
                    <item>
                <title><![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]></title>
                <description><![CDATA[SCHEDULE 13G/A]]></description>
                <link>https://ir.rezolutebio.com/sec-filings/content/0001172661-26-003436/0001172661-26-003436.pdf</link>
                <pubDate>Fri, 14 Aug 26 00:00:00 -0400</pubDate>
                <guid>https://ir.rezolutebio.com/sec-filings/content/0001172661-26-003436/0001172661-26-003436.pdf</guid>
                                                                
            </item>
                    <item>
                <title><![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]></title>
                <description><![CDATA[2 Related Documents: SCHEDULE 13G/A, EX-24]]></description>
                <link>https://ir.rezolutebio.com/sec-filings/content/0000070858-26-000432/0000070858-26-000432.pdf</link>
                <pubDate>Wed, 12 Aug 26 00:00:00 -0400</pubDate>
                <guid>https://ir.rezolutebio.com/sec-filings/content/0000070858-26-000432/0000070858-26-000432.pdf</guid>
                                                                
            </item>
            </channel>
</rss>